Nature – Researchers at WHO’s technology transfer hub complete first step in a project aimed at building capacity for vaccine manufacturing in low- and middle-income countries.
Source: South African scientists copy Moderna’s COVID vaccine
A vaccine authorized in December for use in India may help solve one of the most vexing problems in global public health: How to supply lower-income countries with a COVID-19 vaccine that is safe, effective and affordable.The vaccine is called CORBEVAX. It uses old but proven vaccine technology and can be manufactured far more easily than most, if not all, of the COVID-19 vaccines in use today.
Source: A Texas Team Comes Up With a Covid Vaccine that Could Be a Global Game Changer | Portside
Like Omicron, the discovery of variant IHU “is the outcome of vaccine apartheid,” tweeted Dr. Madhu Pai, chair of epidemiology and global health and McGill University.
Source: New Covid Variant in France the Predictable ‘Outcome of Vaccine Apartheid’: Experts
The key to reanimating public life may also be the linchpin of a global surveillance network.
Source: Vaccine Passports Are Here to Stay. Why Worry?
“This announcement is an important first step in vaccinating the world and halting the pandemic,” said Dr. Peter Hotez, a U.S.-based vaccine scientist.
Source: Unpatented Shot Dubbed ‘The World’s Covid-19 Vaccine’ Wins Emergency Approval in India